(Q34580479)

3 August 2017

1 reference

title

The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal (English)

1 reference

3 August 2017

0 references

0 references

cognitive dysfunction

1 reference

Peter G Lawlor

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

94

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

1836-1853

1 reference

Cognitive failure in patients with terminal cancer: a prospective study

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Aging and cancer in America. Demographic and epidemiologic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Assessment of pain in cognitively impaired older adults: a comparison of pain assessment tools and their use by nonprofessional caregivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Alertness, cognition and morphine in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Psychomotor, respiratory and neuroendocrinological effects of a mu-opioid receptor agonist (oxycodone) in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Psychomotor effects of ketorolac in comparison with buprenorphine and diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Randomised trial of oral morphine for chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Outcome of chronic opioid therapy for non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Driving ability in cancer patients receiving long-term morphine analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Neuropsychological and pharmacokinetic assessment of hospice inpatients receiving morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

The cognitive effects of the administration of narcotic analgesics in patients with cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Reversible, narcotic-associated mental status impairment in patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Altered mental status in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Psychiatric morbidity in terminally ill cancer patients. A prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Unexpected complication of successful nerve block. Morphine induced respiratory depression precipitated by removal of severe pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Morphine-induced ventilatory failure after spinal cord compression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Re: Opioid-induced myoclonus and seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Nonopioid and opioid analgesic pharmacotherapy of cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Infection by human immunodeficiency virus--CD4 is not enough

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Transient cognitive disorders (delirium, acute confusional states) in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

An empirical study of delirium subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Relationship between etiology and phenomenologic profile in delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Opioid hyperexcitability: the application of alternate opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Severe opioid toxicity and somatization of psychosocial distress in a cancer patient with a background of chemical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Opioid use in cancer pain. Is a more liberal approach enhancing toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Opioid rotation: does it have a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Meperidine-induced delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

The relationship of postoperative delirium with psychoactive medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Morphine: pharmacokinetics and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

The Metabolism of Morphine and Heroin in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Detection, isolation and characterization of normorphine and norcodeine as morphine metabolites in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

The analgesic activity of morphine-6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Hydromorphone-3-glucuronide: biochemical synthesis and preliminary pharmacological evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Acute neuropsychiatric findings in a patient receiving fentanyl for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Delirium risk factors in elderly hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Risk Factors for Delirium in Hospitalized Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Oral morphine in cancer pain: influences on morphine and metabolite concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Changes in renal function with aging. Implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

21 January 2018

Aging and pharmacology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Drug-induced cognition disorders in the elderly: incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

High dose morphine use in the hospice setting. A database survey of patient characteristics and effect on life expectancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Age and morphine analgesia in cancer patients with postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Systematic review of factors affecting the ratios of morphine and its major metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Chronic nausea and morphine-6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

The pharmacokinetics of morphine and morphine glucuronides in kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Myoclonic spasms during treatment with high doses of intravenous morphine in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Cognitive impairment in medical inpatients. II: Do physicians miss cognitive impairment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Mental disorders in cancer patients: a study of 100 psychiatric referrals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Delirium presenting with symptoms of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Population-based norms for the Mini-Mental State Examination by age and educational level

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Clarifying confusion: the confusion assessment method. A new method for detection of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

The Memorial Delirium Assessment Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

A symptom rating scale for delirium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Further analyses of the Delirium Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: Assessing delirium in advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Development of an instrument to measure terminal restlessness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

What do cancer patients mean when they complain of concentration and memory problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Opioid rotation for cancer pain: rationale and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Organic brain syndromes and opioid administration for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Opioid rotation for toxicity reduction in terminal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Opioids in pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Controlled-release oxycodone and morphine in cancer related pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Pemoline therapy resulting in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Four cases of severe hepatotoxicity associated with pemoline: possible autoimmune pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Delirium in Terminal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

Management of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Delirium in terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Aging and cancer: geriatric oncology--keynote address to the Integrating Geriatrics into Oncology Education

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Elderly persons' last six months of life: findings from the Hospitalized Elderly Longitudinal Project.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Side-effects of opioids in chronic pain treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Cognitive assessment of cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Psychomotor and cognitive functioning in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Subsyndromal Delirium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

The association of serum anticholinergic activity with delirium in elderly medical patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Importance of Serum Anticholinergic Activity in the Assessment of Elderly Patients with Delirium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Serum anticholinergic activity changes with acute illness in elderly medical patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Explanation for potency of repeated oral doses of morphine?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Age-related morphine kinetics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Delirium at the end of life: critical issues in clinical practice and research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Overdiagnosis of depression in the general hospital

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

The use of environmental strategies and psychotropic medication in the management of delirium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

A prospective multicenter assessment of the Edmonton staging system for cancer pain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Opioid rotation: does it have a role?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Terminal restlessness--its management and the role of midazolam

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Delirium: prevention, treatment, and outcome studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Complicated delirium in a cancer patient successfully treated with olanzapine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10389

7 January 2021

Identifiers

DOI

10.1002/CNCR.10389

1 reference

3 August 2017

1 reference